Abstract
Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations. Here is the second version of these recommendations updated according to the evolution of knowledge on COVID19.
Keywords: Acute lymphoblastic leukemia; Adolescents; COVID 19; Children; SARS-CoV-2.
All Keywords
【저자키워드】 children, adolescents, SARS-CoV-2., COVID 19, Acute lymphoblastic leukemia, 【초록키워드】 Treatment, Evolution, SARS-CoV-2, COVID19, knowledge, SARS-COV-2 infection, Infection, COVID, cancers, leukemia, recommendations, Acute lymphoblastic leukemia, Society, French, recommendation, Lymphoblastic leukemia, Committee, leukemias, the SARS-CoV-2, 【제목키워드】 COVID19, Society, Version, French, recommendation, Committee,
【저자키워드】 children, adolescents, SARS-CoV-2., COVID 19, Acute lymphoblastic leukemia, 【초록키워드】 Treatment, Evolution, SARS-CoV-2, COVID19, knowledge, SARS-COV-2 infection, Infection, COVID, cancers, leukemia, recommendations, Acute lymphoblastic leukemia, Society, French, recommendation, Lymphoblastic leukemia, Committee, leukemias, the SARS-CoV-2, 【제목키워드】 COVID19, Society, Version, French, recommendation, Committee,
{{{ 추상적인 }}}
SARS-CoV-2 감염이 발생한 이후로 많은 권장 사항이 만들어졌습니다. 그러나 급성 림프모구성 백혈병의 특성과 소아 및 청소년에 대한 치료는 프랑스 소아청소년 암 및 백혈병 퇴치 학회(SFCE)의 백혈병 위원회에서 보다 구체적인 권장 사항을 제안하도록 이끌었습니다. 다음은 COVID19에 대한 지식의 발전에 따라 업데이트된 이러한 권장 사항의 두 번째 버전입니다.
{{ 키워드: }} 급성 림프구성 백혈병; 청소년; 코로나 19; 어린이들; 사스 코로나바이러스 2.